[LGND] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -100.47%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 131,314 196,245 277,133 186,419 120,282 251,453 141,102 -1.19%
PBT 63,660 36,011 47,298 -10,538 796,639 173,330 57,231 1.78%
Tax 9,841 41,230 -10,288 -7,553 167,337 30,009 44,675 -22.27%
NP 52,154 -5,219 57,138 -2,985 629,302 143,321 12,556 26.77%
Tax Rate -15.46% -114.49% 21.75% - -21.01% -17.31% -78.06% -
Total Cost 79,160 201,464 219,995 189,404 -509,020 108,132 128,546 -7.75%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 39.72 -2.66 20.62 -1.60 523.19 57.00 8.90 28.29%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 3.02 -0.31 3.44 -0.18 33.13 5.96 0.60 30.89%
EPS Diluted 2.94 -0.31 3.31 -0.18 31.85 5.96 0.53 33.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.